You
← Back to results
FT
Foghorn Therapeutics Inc.Company · Health · MA
RealCurrent
Mission statement · Company scope

“Our mission is to leverage our unique insights into the chromatin regulatory system to pioneer the discovery, development and commercialization of a new class of therapies that transform the lives of patients suffering from a wide spectrum of diseases with high unmet need.”

MissionInnovationLeads with inventionClimate & health
✎ Write one like this
In use2026 – now1 sighting
First seenMar 2026Added
Last seenMar 2026Latest observation
Date created—Not published by the organization
Record
Kind
Mission
Scope
Company
Style
Innovation (primary) · Problem–solution · Impact
Leads with
Invention
Best for
Climate & health
Formula
We’re building [new thing] so [result]
Tone
Plain
Length
43 words · reading grade 22.9
Review status
unreviewed · classifier rules-v0
Quality score
0.60
Record
st_db8084321e737a19
Classification confidence
0.69
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-03-11 · sec_sentence · 10-K · accession 0001628280-26-016814
View filing ↗
Report an issueReports are reviewed within 3 working days.
0 to compareCompare